Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,872

Class I recallsReasonable probability of serious health consequences

24,509

Class II recallsTemporary or medically reversible health consequences

2,932

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,096 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-meat-and-poultry-products-due-misbranding-andPublished November 6, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 8, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

FDA Recall OngoingHistorical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 90-count (NDC: 13668-115-90), b) 1000-count (NDC: 13668-115-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count (NDC: 13668-409-30), b) 90-count (NDC: 13668-409-90), c) 1000-count (NDC: 13668-409-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, a) 90-count (NDC: 13668-113-90), b) 1000-count (NDC: 13668-113-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 23, 2022Historical recordClass II

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

by LUPIN SOMERSET

Reason: Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2020Historical recordClass II

Life-Line tm Catalytic Activated Energy Water, 1 gallon container, McDaniel Life-Line LLC 1775 US Hwy 385 806-647-1741 Dimmitt, TX 79027

by McDaniel Life-Line LLC

Reason: Unapproved new drug
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2020Historical recordClass II

Indian Herb Paste (a dietary supplement) Ingredients: Galangal, Indian Paint, Yellow Dock & Licorice in an alloy of Life-Line tm and Zinc Chloride in 6 dram vials, McDaniel Life-Line LLC, Dimmitt, TX

by McDaniel Life-Line LLC

Reason: Unapproved new drug
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 2, 2021Historical recordClass III

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.

by X-Gen Pharmaceuticals Inc.

Reason: Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 27, 2020Historical recordClass III

Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631, 562-352-9630.

by Auro Pharmacies Inc. DBA Central Drugs

Reason: Failed pH Specification: product does not meet pH label claim.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: July 5, 2019Historical recordClass I

Theo Chocolate Inc

Product: Sea Salt 70% Dark Chocolate 3 oz. bars, wrapped in foil and…
Reason: Theo Chocolate Sea Salt 70% Dark Chocolate Bar is recalled due to undeclared milk.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: July 26, 2019Historical recordClass II

GOOD KARMA FOODS INC

Product: PL Trader Joe Natural Creamer - Vanilla 12/32oz, Plastic bot…
Reason: Product was recalled due to undeclared milk. The Contains statement does not list milk as an ingredient.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 28, 2020Historical recordClass III

Merical, LLC

Product: Walgreens Probiotic 12.5 Billion Active Cultures, 30 capsule…
Reason: Incorrect probiotic strain used in formulation which did not match product labeling.
Published: April 17, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: April 17, 2019Historical recordClass II

Impossible Foods

Product: Impossible Foods Bulk, 5 lb. vacuum sealed plastic-pack. Ke…
Reason: Piece of plastic was found in bulk product.
Published: April 17, 2019
Distribution: Multiple states

View recall →

FDA Recall TerminatedTerminated: February 4, 2021Historical recordClass II

NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF), 4 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321674481

by KRS Global Biotechnology, Inc

Reason: Labeling: Label mix-up
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 4, 2021Historical recordClass II

NORepinephrine 16 mg added to 0.9% Sodium Chloride (PF), 16 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321678343

by KRS Global Biotechnology, Inc

Reason: Labeling: Label mix-up
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 23, 2021Historical recordClass II

Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742

by Johnson Matthey Inc.

Reason: Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 20, 2019Historical recordClass II

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

by Jubilant Cadista Pharmaceuticals, Inc.

Reason: Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 11, 2022Historical recordClass III

Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA. NDC 47781-621-94

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 11, 2022Historical recordClass III

Clindamycin Injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC 47781-620-94

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 11, 2022Historical recordClass III

Clindamycin Injection, USP, 300 mg/ 2 mL (150 mg/mL), 2 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA.,NDC 47781-619-94

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Published: April 10, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 11, 2022Historical recordClass III

Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Published: April 10, 2019
Distribution: Nationwide

View recall →

Data last updated: November 8, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.